Mayo Clinic

In Genome Biology this week: approach to analyze alternative polyadenylation, algorithm to predict transcriptomic structural variations, and more.

With integrated data for thousands of TCGA tumors, teams explored cancer subtypes, searched for prognostic insights, began mapping immune cell interactions, and more.

Researchers saw clinically actionable heart disease mutations in fewer than 5 percent of sudden infant death syndrome cases interrogated by molecular autopsy.

Investigators identified mutation, expression, and methylation differences in colorectal polyps from individuals with or without colorectal cancer.

The partners are developing and optimizing an algorithm that assesses the likelihood of a patient's cancer progressing to metastasis.

Mayo Clinic is taking an ownership stake in sequencing startup Veritas Genetics as it integrates genomics expertise into the myGenome WGS platform.

Convince Him

One Mayo Clinic doctor isn't sure of the value of genome sequencing, NPR reports.

The Mayo Clinic will apply PathoQuest's next-generation sequencing-based iDtect Blood test in a study to identify febrile neutropenia in patients.

Research teams documented mosaic mutations during brain development, as well as rising somatic mutations in aging brains or brains affected by neurodegenerative disease.

This Week in PLOS

In PLOS this week: de novo mutations in epileptic encephalopathy, sequencing analysis of aromatic rice, and more.

Pages

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.